September 14, 2018. The NCHR testifies at the FDA advisory board committee for tobacco products regarding advertisements that target the youth.
Read More »Author: Caroline Bradford
NCHR Testimony on Pediatric Advisory Committee Meeting for Drugs Lexapro, Intuniv, and Desferasirox
September 20, 2018. NCHR Testimony on Pediatric Advisory Committee Meeting for drugs Lexapro, Intuniv and Desferasirox. This meeting was to go over the safety profiles of the aforementioned drugs, label profiles as well as recent clinical studies done.
Read More »Summary of Published Study by MD Anderson Physicians on the Increase in Rare Diseases Among Women with Breast Implants
September 17, 2018. We summarize the study conducted by MD Anderson Cancer Center regarding the incidence of rare diseases among women with breast implants.
Read More »Statement of Dr. Diana Zuckerman, President of the National Center for Health Research Regarding the New Study of 100,000 Women with Breast Implants
NCHR President Dr. Diana Zuckerman makes a statement in support of the MD Anderson study on breast implants causing illness.
Read More »NCHR Comments on the FDA’s Experimental Study of Risk Information Amount and Location in Direct-To-Consumer Print Ads
The NCHR makes comments to the FDA on an experimental study that examines the way consumers look at the location of risk information for drugs in print-ads.
Read More »